Stocksigma LogoStocksigma Logo

Lincoln Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

■ Revenue: 19,135 (+17.1% YoY | +7.9% QoQ) ■ EBITDA: 2,369 (-6.8% YoY | -13.7% QoQ) ■ EBITDA Margin (%): 12.4 (-319 bps YoY | -309 bps QoQ) ■ PAT: 2,043

Lincoln Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

Lincoln Pharmaceuticals Ltd · Outcome · 29 Oct 2026, 5:51 pm

Lincoln Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 19,135 (+17.1% YoY | +7.9% QoQ) ■ EBITDA: 2,369 (-6.8% YoY | -13.7% QoQ) ■ EBITDA Margin (%): 12.4 (-319 bps YoY | -309 bps QoQ) ■ PAT: 2,043 (+2.2% YoY | -43.6% QoQ) ■ EPS (INR): 10.2 (+2.2% YoY | -43.6% QoQ)

Original exchange filing (PDF)

More announcements from Lincoln Pharmaceuticals Ltd

All Lincoln Pharmaceuticals Ltd announcements